Replies to post #12671 on Cytogenix (fka CYGX)

[peace_2_all]

I am looking to the day CYGX will do the same. The financials of NEOL are terrible with almost no revenue and over 40 mill debt, lol! Trades on future potentials only. That is why I am saying CYGX should trade a lot higher once we have phase I/II trials of some of its products. I am looking forward to that day, and hopefully soon.